22 related articles for article (PubMed ID: 10780678)
1. Molsidomine ameliorates diabetic peripheral neuropathy complications in Wistar rats.
Nayak B P; Minaz N; Pasha K
Animal Model Exp Med; 2021 Sep; 4(3):243-248. PubMed ID: 34557650
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of glyoxalase I in a streptozocin-induced mouse model of diabetes with painful and insensate neuropathy.
Jack MM; Ryals JM; Wright DE
Diabetologia; 2011 Aug; 54(8):2174-82. PubMed ID: 21633909
[TBL] [Abstract][Full Text] [Related]
3. Treatment with NADPH oxidase inhibitor apocynin alleviates diabetic neuropathic pain in rats.
Olukman M; Önal A; Celenk FG; Uyanıkgil Y; Cavuşoğlu T; Düzenli N; Ülker S
Neural Regen Res; 2018 Sep; 13(9):1657-1664. PubMed ID: 30127129
[TBL] [Abstract][Full Text] [Related]
4. Altered Semmes-Weinstein monofilament test results are associated with oxidative stress markers in type 2 diabetic subjects.
Martinez-Hervás S; Mendez MM; Folgado J; Tormos C; Ascaso P; Peiró M; Real JT; Ascaso JF
J Transl Med; 2017 Sep; 15(1):187. PubMed ID: 28874161
[TBL] [Abstract][Full Text] [Related]
5. Anti-Apoptotic Effect of IGF1 on Schwann Exposed to Hyperglycemia is Mediated by Neuritin, a Novel Neurotrophic Factor.
Yan L; Xie M; Lu H; Zhang H; Shi M; Zhang Y; Xi C; Li J; Yang T
Mol Neurobiol; 2018 Jan; 55(1):495-505. PubMed ID: 27966079
[TBL] [Abstract][Full Text] [Related]
6. Hyperlipidemia: a new therapeutic target for diabetic neuropathy.
Vincent AM; Hinder LM; Pop-Busui R; Feldman EL
J Peripher Nerv Syst; 2009 Dec; 14(4):257-67. PubMed ID: 20021567
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide synthase activity and expression in experimental diabetic neuropathy.
Zochodne DW; Verge VM; Cheng C; Höke A; Jolley C; Thomsen K; Rubin I; Lauritzen M
J Neuropathol Exp Neurol; 2000 Sep; 59(9):798-807. PubMed ID: 11005260
[TBL] [Abstract][Full Text] [Related]
8. Effects of trolox on nerve dysfunction, thermal hyperalgesia and oxidative stress in experimental diabetic neuropathy.
Sharma SS; Sayyed SG
Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1022-8. PubMed ID: 17042909
[TBL] [Abstract][Full Text] [Related]
9. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy.
Low PA; Nickander KK; Tritschler HJ
Diabetes; 1997 Sep; 46 Suppl 2():S38-42. PubMed ID: 9285497
[TBL] [Abstract][Full Text] [Related]
10. Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy.
Sayyed SG; Kumar A; Sharma SS
Life Sci; 2006 Jul; 79(8):777-83. PubMed ID: 16581090
[TBL] [Abstract][Full Text] [Related]
11. Free radical scavenging enzymes in fetal dysmorphogenesis among offspring of diabetic rats.
Sivan E; Lee YC; Wu YK; Reece EA
Teratology; 1997 Dec; 56(6):343-9. PubMed ID: 9485543
[TBL] [Abstract][Full Text] [Related]
12. Gene expression of antioxidant enzymes in experimental diabetic neuropathy.
Kishi Y; Nickander KK; Schmelzer JD; Low PA
J Peripher Nerv Syst; 2000 Mar; 5(1):11-8. PubMed ID: 10780678
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
